300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Email
Retail
Oil and Gas
Payments
Film
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Biotechnology
Legal
Automotive
eSports
Renewable Energy
Software
Facebook
Blockchain
Theatre
Medical
Beauty
Fashion
Infrastructure
Social
Web3
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Recruiting
Wine and Spirits
Mobile Apps
Real Estate
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Sporting Goods
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Music
Art
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Zimbabwe
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Moldova
Botswana
Seychelles
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Bangladesh
Cyprus
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Vinnof, VC Fund

Vinnof

VC Fund

Brussels, Belgium

Vinnof is a venture capital firm that offers seed capital to innovative, early-stage startups based in Flanders, Belgium.

Total investments:
5
Last investment:
Lead investor:
20%

Last updated:

Industries Vinnof invests in

BiotechnologyHealth CareMedicalTherapeuticsBig Data

Stages Vinnof invests in

Series ASeedSeries BFunding Round

Countries Vinnof invests in

BelgiumUnited Kingdom

Round sizes

Series A $9.3M–$11M

Contacts

NameEmailPhoneSocials
See all 11 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$9.3M–$11M

Investment Focus

Industry

  • Biotechnology 4 (80%)
  • Health Care 3 (60%)
  • Medical 2 (40%)
  • Therapeutics 2 (40%)
  • Big Data 1 (20%)
See all 13 industries →

Stage

  • Series A 2 (40%)
  • Seed 1 (20%)
  • Series B 1 (20%)
  • Funding Round 1 (20%)

Country

  • Belgium 4 (80%)
  • United Kingdom 1 (20%)

Team

NameTitleInvestmentsLinksEmail
Chris De Jonghe
Chris De Jonghe Member, Group Management Committee
Member, Group Management Committee Total investments: 3
Find email
Chairman Total investments: 0 Find email
Christine Claus
Christine Claus Director
Director Total investments: 0
Find email
Clair Ysebaert
Clair Ysebaert Director
Director Total investments: 0
Find email
Greta D'Hondt
Greta D'Hondt Director
Director Total investments: 0 Find email
See all 11 team members →

Investments

CompanyDescriptionRoundLinks
Loshai is a unified Predictive platform that allows that allows data integration, modelling and visualisation using no-code tools . It provides 360 analytics insights on data along with simulations based o what-if scenarios using AI loops. LoshAi's simple UI allows mapping just enough data to answer the business questions at hand. Schema-lessintegration across OT and IT sources. Seed / Sep 08, 2022
Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins. $15.6M / Series B / Jun 26, 2013
Okapi Sciences NV, a Belgium-based company with a proprietary pet therapeutics antiviral platform and five clinical/development stage candidates for treating important viral diseases. The strategic acquisition of Okapi further enhances Aratana's leadership position in pet therapeutics by bringing with it a unique combination ofindividuals, strong relationships with academic institutions, novel technologies and products, and favorable geographic location. Aratana plans to continue to advance the current Okapi pipeline of high value antiviral drugs, including its feline herpes and feline immunodeficiency virus franchises. $9.3M / Series A / Nov 03, 2008
Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, Factor VIII intolerance and uveitis. The company, whose first product candidate is licensed to Merck Serono, will now progress its remaining portfolio of productcandidates developed with its proprietary platform technology. $11M / Series A / Oct 30, 2008
Formac is a spin-off company from the University of Leuven, Belgium (K.U.Leuven), from which it has obtained the exclusive and worldwide rights to develop and commercialise ordered mesoporous silica materials for the delivery of poorly soluble API's. The company was incorporated on 3 October 2007 and is privately owned. The main shareholdersof Formac are K.U.Leuven, Allegro Investment Fund, Hunza Ventures, Gemma Frisius Fonds K.U.Leuven, Vinnof PMV and Life Sciences Research Partners VZW (formerly D. Collen Foundation).Since its incorporation Formac has signed more than 40 feasibility agreements with Tier 1 Pharma companies and SMEs in the field of human and veterinary medicine. To date, Formac is the only company that demonstrated the clinical relevancy of the silica based technology in a clinical setting. $1.9M / Nov 08, 2007

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Email
Retail
Oil and Gas
Payments
Film
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Biotechnology
Legal
Automotive
eSports
Renewable Energy
Software
Facebook
Blockchain
Theatre
Medical
Beauty
Fashion
Infrastructure
Social
Web3
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Recruiting
Wine and Spirits
Mobile Apps
Real Estate
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Sporting Goods
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Music
Art
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Zimbabwe
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Moldova
Botswana
Seychelles
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Bangladesh
Cyprus
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Vinnof invest in?

Vinnof invests primarily in Biotechnology, Health Care and Medical startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Vinnof invest in?

Vinnof typically joins rounds of $9.3M–$11M at Series A. These are whole funding-round sizes, not Vinnof's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Vinnof took part in.

How do I contact Vinnof?

Public channels for Vinnof include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Vinnof?

The team at Vinnof includes Chris De Jonghe (Member, Group Management Committee), Marcel Van Hoven Hand (Chairman) and Christine Claus (Director), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Vinnof Vinnof Find emails